Immune regulation by CD40 and its ligand GP39

被引:547
|
作者
Foy, TM
Aruffo, A
Bajorath, J
Buhlmann, JE
Noelle, RJ
机构
[1] DARTMOUTH COLL SCH MED,BIOCHEM GRAD PROGRAM,LEBANON,NH 03756
[2] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,SEATTLE,WA 98121
关键词
CD40; CD40L; gp39; structure; peripheral tolerance; central tolerance;
D O I
10.1146/annurev.immunol.14.1.591
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Over the past three years, CD40 and its ligand (gp39, CD40L, TBAM) have been shown to be essential for humoral immune responses to thymus-dependent antigens. However, as the tissue distribution widens for those cells that express CD40 and gp39, we can now show that this ligand-receptor pair also plays an important role in the selection of self-reactive T cells in the thymus (central tolerance) and the regulation of tolerance in mature T cells (peripheral tolerance). Advances in our understanding of the molecular basis for CD40 biology is based in two areas of research. First, a major breakthrough in our understanding of how CD40 transduces biological events centers on the identification of a novel protein that binds to the cytoplasmic tail of CD40 and may act as a signal transducing molecule. Secondly, advances in molecular modeling and mutagenesis of this ligand-receptor pair have helped to identify the critical receptor/ligand contacts in the gp39/CD40 complex. Advances in each of these areas are discussed.
引用
收藏
页码:591 / 617
页数:27
相关论文
共 50 条
  • [1] REGULATION OF THE EXPRESSION OF GP39, THE CD40 LIGAND
    ROY, M
    NOELLE, R
    FASEB JOURNAL, 1994, 8 (05): : A1015 - A1015
  • [2] Functions of CD40 and Its Ligand, gp39 (CD40L)
    Leman, Jon D.
    Claassen, Eric
    Noelle, Randolph J.
    CRITICAL REVIEWS IN IMMUNOLOGY, 2017, 37 (2-6) : 371 - 420
  • [3] Functions of CD40 and its Ligand, gp39 (CD40L)
    Laman, JD
    Claassen, E
    Noelle, RJ
    CRITICAL REVIEWS IN IMMUNOLOGY, 1996, 16 (01) : 59 - 108
  • [4] Signaling functions of the CD40 Receptor - CD40 Ligand (gp39) pair♦ 39
    Birgit C Brenner
    Erich Gulbins
    Ursula Koppenhoefer
    Florian Lang
    Otwin Linderkamp
    Pediatric Research, 1997, 41 (Suppl 4) : 9 - 9
  • [5] Therapeutic potential for blockade of the CD40 ligand, gp39
    Buhlmann, JE
    Noelle, RJ
    JOURNAL OF CLINICAL IMMUNOLOGY, 1996, 16 (02) : 83 - 89
  • [6] AN ESSENTIAL ROLE FOR GP39, THE LIGAND FOR CD40, IN THYMIC SELECTION
    FOY, TM
    PAGE, DM
    WALDSCHMIDT, TJ
    SCHONEVELD, A
    LAMAN, JD
    MASTERS, SR
    TYGRETT, L
    LEDBETTER, JA
    ARUFFO, A
    CLASSEN, E
    XU, JCC
    FLAVELL, RA
    OEHEN, S
    HEDRICK, SM
    NOELLE, RJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05): : 1377 - 1388
  • [7] INTERACTION BETWEEN CD40 AND ITS LIGAND GP39 IN THE DEVELOPMENT OF MURINE LUPUS NEPHRITIS
    MOHAN, C
    SHI, Y
    LAMAN, JD
    DATTA, SK
    JOURNAL OF IMMUNOLOGY, 1995, 154 (03): : 1470 - 1480
  • [8] ALLOGENEIC TOLERANCE INDUCED BY TREATMENT WITH AN ANTIBODY TO THE LIGAND FOR CD40, GP39
    DURIE, FH
    MACKEY, MF
    FOY, TM
    ARUFFO, A
    APPEL, MC
    CRASSI, KM
    LEDBETTER, JA
    GREEN, W
    NOELLE, RJ
    FASEB JOURNAL, 1994, 8 (04): : A477 - A477
  • [9] THE REGULATION OF THE EXPRESSION OF GP39, THE CD40 LIGAND, ON NORMAL AND CLONED CD4+ T-CELLS
    ROY, M
    WALDSCHMIDT, T
    ARUFFO, A
    LEDBETTER, JA
    NOELLE, RJ
    JOURNAL OF IMMUNOLOGY, 1993, 151 (05): : 2497 - 2510
  • [10] PREVENTION OF COLLAGEN-INDUCED ARTHRITIS WITH AN ANTIBODY TO GP39, THE LIGAND FOR CD40
    DURIE, FH
    FAVA, RA
    FOY, TM
    ARUFFO, A
    LEDBETTER, JA
    NOELLE, RJ
    SCIENCE, 1993, 261 (5126) : 1328 - 1330